Samantha Genardi

Samantha Genardi, PhD, has had a diverse range of work experiences in the field of scientific research. Samantha is currently employed at Cour Pharmaceuticals Development Company, Inc. as a Senior Scientist and Program Manager. Prior to this role, they were a Researcher PhD Student at Northwestern University's Feinberg School of Medicine, where they focused on the role of natural killer T cells in a murine sepsis model of MRSA infection. Samantha'sresponsibilities included conducting experiments, analyzing data, and characterizing cytokine production and kinetics during infection.

In addition, Samantha has also worked as a Research Scholar at the Ann & Robert H. Lurie Children's Hospital of Chicago, where they participated in the KIICS research program for PhD students interested in translational medicine. Samantha was a Summer Intern at the Dana-Farber Cancer Institute, where they contributed to the molecular biology group by cloning designed sequences and creating cell lines expressing CRISPR-Cas9 target sequences.

Samantha's earlier experiences include working as a Researcher in the DNA Damage Recognition and Tolerance Lab at Northeastern University, where they characterized putative mutagenesis cassettes in Sinorhizobium meliloti for their undergraduate honors thesis. Samantha was also a Medical Oncology Co-op at the Dana-Farber Cancer Institute, studying knockdown of library screened cancer biomarkers and its effects on gastric cancer lines.

Furthermore, Samantha has gained valuable industry experience as a Co-op in the Encoded Library Technology (ELT) group at GlaxoSmithKline. Samantha'sresponsibilities included aiding in the development and production of a library, as well as organizing building blocks and validating libraries.

Overall, Samantha Genardi, PhD, has a strong background in scientific research, with expertise in infectious diseases, cancer biology, and molecular biology.

Samantha Genardi, PhD, completed their education in the field of Immunology. Samantha obtained their Doctor of Philosophy (Ph.D.) from Northwestern University, where they studied from 2014 to 2020. Prior to that, they earned a Bachelor of Science (BS) degree in Biochemistry from Northeastern University, where they attended from 2010 to 2014. Additionally, Samantha has obtained certification in Clinical Pharmacology, Drug Development, and Regulation through the Tufts Center for the Study of Drug Development. Samantha completed the Tufts CSDD Postgraduate Course in April 2022.